DeviceTalks Podcast Network (DeviceTalks)

Shacey Petrovic, CEO and president of Insulet, explains how the company is giving people with diabetes new tools to manage their disease, a never-ending task that can require HUNDREDS of decisions per day. In this interview, Petrovic explains why research wasn't for her; why she decided to leave her first CEO job to join Insulet; and how the company is building the a glucose-delivery device that could convince people with diabetes to give up the certainty of the shot. In this episode, we also hear from Dr. Niki Panich, a practicing physician who is now CEO of a company that can help hospitals and health care facilities process their N95 masks on site. Dr. Panich will be a speaker on this Monday's DeviceTalks Clubhouse series. Finally, Chris Newmarker delivers the big news of the week involving Baxter, Adaptive Biotechnologies, Boston Scientific, Abbott, and AdvaMed.

HAPPY BIG 5-0!! This week’s is our 50th DeviceTalks Weekly Podcast, and we’re going to celebrate! Ashley McEvoy, Executive Vice President, Worldwide Chairman, Medical Devices, Johnson & Johnson, makes her DeviceTalks Weekly debut. In this update, McEvoy delivers great insights on several areas of interest including: • COVID-19’s impact on J&J in the past, and what changes may remain in the future. • J&J’s far-ranging digital surgery portfolio could bolster many of its specialties. • How the company uses its innovation network to accelerate development • Why she’s bullish on the future of eye care. • How the company will prepare for future challenges. We also talk with Naomi Murray, Director of Advanced Operations-Additive Technology at Stryker about her almost predestined path to join the orthopedics leader. She’ll be leading the March 23 discussion on Additive Manufacturing at DeviceTalks Tuesday. Register at DeviceTalks.com. Colleague Lisa Eitel, executive editor of Design World, crashes the party to tell us about her upcoming Women in Engineering webcast. Register for that discussion at https://www.designworldonline.com/design-world-online-events-and-webinars/ Finally, Chris Newmarker delivers some good news and bad Newmarker's Newsmakers from the digital pages of MassDevice, Medical Design & Outsourcing, and other sites. Companies highlighted include Frequency, Medtronic, Theranos, GE Healthcare, DJO and Stryker Subscribe now on any major podcast channel. Google. Apple. Spotify. Amazon, etc.

Former Kinetic Concepts CEO Catherine Burzik takes you inside the $6.1 billion merger of Kinetic Concepts with Apax Partners in 2011, the largest leveraged buyout since the fall of Lehman Brothers.

Johnson & Johnson's Global Medical Solutions Group Worldwide Chairman Karen Licitra talks about her role within Johnson & Johnson and how she thinks the economics of healthcare and the medical device industry need to change in order to accommodate the future.

MassDevice reporter Brad Periello speaks with CEO and founder of NxStage Medical Jeff Burbank, Zoll CEO Richard Packer, ConforMIS CEO Philipp Lang, and Ocular Therapeutix CEO Amar Sawhney about what it takes to keep companies on the cutting edge, as well as their ups and downs as heads of major medtech companies.

Hologic CEO Steve MacMillan says last March he didn’t appreciate how COVID-19 would change the world forever. But the diagnostics company quickly rose to the challenge, creating one of the surer supplies of diagnostic tools to chart the pandemic's severity. In this DeviceTalks Weekly Podcast, MacMillan shares how Hologic pivoted to meet the calls for help from political leaders in the US and around the world. He also shares what’s next for the company which has shed its aesthetics business in favor of a tighter new course, a course that includes the creation of an innovative information index that will yield new data on women’s health. While Hologic rose to the challenge during the pandemic, GuardianLane is ready to help children who are coping with grief, including the loss of loved ones to COVID-19 and other diseases. CEO Kristina Jones shares the story that won the first pitch contest held by Medtech Color, an organization founded to help people of color thrive in the medical device industry. We’ll also hear from our sponsor, PackWorld USA, a leader in heat sealing technology. Chris Newmarker, executive editor of MassDevice, delivers this week’s Newmarker's Newsmakers including news from ThermoFisher Scientific, Second Sight, Boston Scientific and Medtronic. Senior Editor Danielle Kirsh also joins us to review her overview on how top medical device are faring a year after the start of the pandemic. https://www.medicaldesignandoutsourcing.com/how-big-medtech-fared-during-a-year-of-covid-19/ Subscribe now on all major podcast channels.

This week, we’ll talk with Lisa Earnhardt, executive vice president, medical devices at Abbott about how the life sciences giant pivoted during the pandemic. Earnhardt shares what programs were given greater priority when the impact of the lockdown became clear and why the company performed so well in one of its key businesses. We also explore this week’s news that the FTC will oppose Illumina’s acquisition of Grail. First, we talk with Dr. Christopher Keir, vice president of medical affairs at Grail, about the great potential of the company’s diagnostic technologies. The interview was recorded last month prior to the FTC’s decision. Then we talk to Vijay Kumar, senior managing director at Evercore ISI, about why the FTC is making a strong case to block the deal. And, of course, Chris Newmarker, executive editor of Mass Device, delivers this week’s Newmarker’s Newsmakers including news from Illumina, Grail, Corindus, Zimmer Biomet, BD, Medtronic and Abbott. Finally, don’t forget to join us on Clubhouse for DeviceTalks Weekly Live at 1 pm ET on Wed.

In this week’s podcast, Derek Herrera explains how a serious battle injury he received while leading Marines in Afghanistan led him to build a career in medtech. Herrera has founded two companies – Spinal Singularity and Habit Camera – to create devices that can improve and save the lives of people who need help the most. Herrera also explains how his military training is serving him so well in medtech and how the medical device industry would benefit from including more veterans in its workforce. We’ll also hear from Kwame Ulmer, principal at Ulmer Ventures and a lecturer at UCLA Anderson’s School of Management, about an effort his helping to lead to update the landmark study compiled by Josh Makower in 2010. The study blasted a regulatory process that it called “unpredictable, inefficient and expensive.” Its finding led to introspection and changes, according to Ulmer who served at the FDA at the time. Now Ulmer is working with UCLA leaders to update the study. He’s hoping to connect with 200 medical device and digital health executives to understand how they’re working with the agency. For more information go to MedtechStudy.com. For more information on the original study go here - https://www.massdevice.com/study-fda-related-activities-cost-24-million-510k/ Meanwhile, Medtech Media Mogul Chris Newmarker, executive editor of life sciences, will unveil his Newmarker’s Newsmakers including reports from Google, Varian, Boston Scientific, Hologic, LumiraDx, and a report detailing racial inequity in how LVADs are implanted. Subscribe to this podcast on all major podcast applications.

This week, Liane Teplitsky, vice president and general manager of worldwide robotics at Zimmer Biomet, shares her excitement for the burgeoning data business emerging in orthopedics. Teplitsky, an engineer who built her medtech career in the cardiac R&D and sales at St. Jude and Abbott, walks us through the interconnected offerings of Zimmer’s ZBEdge suite of digital and robotics technologies. We also speak with Achuta Kadambi, assistant professor to the UCLA Samueli School of Engineering, about a column he contributed to Science suggesting physics may be causing medical devices to perform at varying levels in people of different races. Kadambi explains his own work in the field and suggests how medical device developers may want to move forward in the future. Go here to read the MDO article on this topic and find the link to the Science column. https://www.medicaldesignandoutsourcing.com/ucla-prof-racial-bias-in-medical-devices-based-in-physics/ Chris Newmarker of MassDevice reports on another SPAC ATTACK in this week’s Newsmarker’s Newsmakers – Siemens Healthineers, Varian, Zoll, Respicardia, Endologix, PQ Bypass, Vicarious Surgical, Medline Industries. And find out what happened to that chicken.... Subscribe today on all major podcast channels.

In this podcast, iRhythm CEO Mike Coyle discusses his decision to join the digital health leader in January. Coyle’s had to hit the ground running as iRhythm manages some challenging decisions from regional Medicare payors but he also sees great opportunity for the company’s ZIO platform across the healthcare spectrum. In this conversation, Coyle discusses • How he came to join the Medtech industry. • The potential for its ZIO cardiac monitoring technology • How the company is dealing with a disappointing reimbursement • How the company will pursue the large asymptomatic market • What’s expected to come from the company’s partnership with Verily We also introduce the newest member of our DeviceTalks Podcast family. Catch an excerpt of the first episode in this week’s podcast. Subscribe to hear future episodes. Caffeine-fueled Chris Newmarker, executive editor of life sciences at Mass Device, takes a break from earnings week to roll out a powerful #newmarkersjnewmakers bringing news from Zimmer Biomet, Stryker, Emergent Biosolutions, Intuitive Surgical, Medtronic and NeuroPace. Subscribe on all major podcast players.

Can Proximie bring safer surgery to the wider world? How is Getinge answering call for ventilators? In this week’s podcast senior executives from Getinge and Proximie – two very different sized companies – explain how the COVID-19 pandemic accelerated their business. In the opening keynote conversation, Eric Honroth, president, Getinge North America, explained how the company more than doubled its production of ventilators in 2020. He also discusses recent FDA clearances for two lines of critical devices. In our closing keynote, Dr. Nadine Hachach-Haram, CEO and founder of Proximie, says the start-up reached its 2023-24 projected size in just a few months as hospitals and medical device companies sought the ability to collect surgeons to the outside world. Dr. Hachach-Haram, a reconstructive surgeon, gives a detailed account of how a growing shortage of surgeons convinced her to start a technology company. She also shares how the technology ultimately restored the life of someone very close to her. Chris Newmarker, executive editor of MassDevice, offers up his Top 5 Newmarker’s Newsmakers including news about human-monkey embryos, Abbott, Stryker, Medtronic and DJO. Don't forget to subscribe to this podcast! And our new MedtronicTalks podcast.

In this episode, two of the executives leading Medtronic’s push into robotics surgery update listeners on the progress and potential of Medtronic's MAZOR X Stealth and Hugo RAS system platforms. Megan Rosengarten, president of surgical robotics, says HUGO is poised to deliver surgeons newfound capabilities and options. The company hopes to begin selling the system later this year after filing for a CE Mark in Europe and an IDE with the US Food and Drug Administration. Chris Newmarker, executive editor of life sciences at MassDevice, delivers this week’s Newmarker’s Newsmakers including reports from Neuroelectrics, Medtronic, and Apple. Danielle Kirsh, senior editor, also updates listeners on her recent report on four catheter-based devices to watch for this year. Also, an update from our underground medtech analyst – Barry the Groundhog. Please subscribe on all major podcast channels - Amazon, Apple, Google, Spotify

Jeff Mirviss, executive vice president of Boston Scientific’s peripheral business, explains why the specialty’s name doesn’t really reflect the importance of arteries, veins and other “highways” that his business group is addressing. Mirviss explains where the peripheral business is headed, and why Boston Scientific is uniquely positioned to address the business. He also shares lessons learned over his 20-plus years at Boston Scientific including the challenges presented by the Guidant acquisition and the new spirit infused by CEO Michael Mahoney. We also speak with Eric Kolodziej, corporate vice president and global head quality and regulatory affairs at Hologic, about how clinical trial management is changing. What role will real world evidence play going forward, and how will Hologic and others follow up on the record number of EUA’s issued over the past year by the FDA. Chris Newmarker, executive editor of life sciences at Mass Device, delivers his Newmarker’s Newsmakers bringing news from Medtronic, Abbott, Zimmer Biomet and Shockwave. Pharma Editor Brian Buntz also sits in the virtual booth to talk about the new Pharma 50 report compiled by our editorial team. Subscribe today on most major podcast applications

This week, the DeviceTalks Weekly Podcasts delivers some learning. First, Dr. Nick West, CMO & divisional VP of global medical affairs at Abbott’s vascular business, discusses the European launch of the company's new coronary imaging platform. Dr. West explains how the AI-powered platform works and the benefits it offers for decision-making during coronary stenting procedures. He also delves into the AI-based technology behind the platform and the direction both imaging and medtech as a whole are heading with AI. Then, Mike Carrel, CEO and president of AtriCure, explains how the company became a force focusing on the atrial fibrillation (Afib) and left atrial appendage (LAA) markets. Carrel walks listeners through the company’s efforts to expand its reach into the connected pain management market. But then he makes a strong case building out its Afib pipeline which includes the EPi-Sense System, which in April received FDA approval to treat patients diagnosed with long-standing persistent atrial fibrillation. Sean Whooley, associate editor at MassDevice, delivers this week’s Newmarkers Newsmakers with updates from Google, Memic (SPAC ATTACK!), Medtronic, Teleflex, and Abbott.

This week we’ll explore innovation and social equity. First, we’ll hear a portion of an interview with Martha Ha, chief privacy officer and chief counsel of corporate governance, and Jon de Csepel, CMO, vice president, medical affairs of the Americas. The pair will explain how the company is reaching out to employees of Asia and Pacific Island and helping them to understand how to better work within the corporate culture. The entire interview can be heard in the latest MedtronicTalks Podcast Josh Makower, MD, is our closing keynote guest. Makower quite possibly invented modern day medtech innovation. In this interview, Makower shares his earliest inventions – kind of mind-blowing – and how his early work at Pfizer helped him create the innovation process used today by biodesign programs across the world, including Stanford Biodesign where Dr. Makower will take over as director this fall. This interview is essential for any individual or organization that wants to innovate. Chris Newmarker, executive editor of life sciences at MassDevice, returns to the podcast with a Newmarker’s Newsmakers that highlights COVID-19, Rapid Medical, iRhythm, Elizabeth Holmes and Medtronic. Tom Salemi also has big news! Subscribe to this podcast on Apple Podcasts, Google, Spotify, Amazon and other major platforms.

In this week’s podcast, Chris Newmarker, executive editor of life sciences, speaks with Laura Rector, Smith + Nephew’s vice president of ambulatory surgery centers and digital health, about the company’s ARIA care management platform. The system uses 3D imaging, artificial intelligence and other tools to help patients recover more quickly from large joint replacement surgery. What’s next for the ortho leader? Meanwhile, Kaila Krum, managing director of Truist Securities, delivers insights on two major stories of the week – the decision by Mike Coyle to leave the CEO post at iRhythm and Medtronic’s decision to pull its Heartware HVAD off the shelves. Those two stories topped this week’s Newmarker’s Newsmakers, which also include items featuring Abbott, Abiomed and the FDA. Subscribe on Google, Amazon, Apple, Spotify, and other leading podcast channels.

A year ago, Geoff Martha took over as CEO of medtech's large single company. With the sector in lockdown, the company still undertook a massive reorganization and moved to adopt a new "Medtronic Mindset" that would favor the bold. In this interview, Martha reviews Year 1, sharing some positive outcomes and disappointments. Chris Newmarker, executive editor of life sciences, delivers his Newmarkers Newsmakers featuring items from Abbott, Amazon, CVRx, Medtronic, and migraines. Subscribe on all major podcast platforms - Apple, Google, Amazon, Spotify.

Nicole J. Walker, managing partner, Arboretum Ventures, tells a unique medtech story that begins with her sick grandfather and follows up with her refusal to remove her foot from the door at Advanced Cardiovascular Systems. She says she learned early on that she may not always have all the answers when making a decision but she would have the instincts and mettle to push through. This combination moved through jobs at Guidant, Abbott, Baird and now Arboretum Ventures where she sees an enormous opportunity finding medical device companies.

In this week's DeviceTalks Weekly Podcast, Minnetronix CEO Jeremy Maniak explains how the CMO is using internal know how to develop medical devices that can be sold by outside partners. We also hear from Dr. James Min of Cleerly Health about that company's start and the process that went into raising $43 million. Chris Newmarker, executive editor of life sciences at MassDevice, is back to deliver his NewmarkersNewsmakers including news from Costa Rica, Vicarious Surgical, Ethicon, Medtronic and ResMed. Subscribe to this podcast today on all major podcast channels.

This week we’ll focus on investor insights. First, we’ll talk with Danielle Antalffy, managing director at SVB Leerink. Antalffy covers most of the major medtechs but we’ll focus on a new report she issues on sugaring home-based dialysis business. What does this mean for Outset specifically? More broadly, do other medtechs need to build out their at-home/connectivity function? Also, what does NeuroPace’s success mean for other medtech companies. In a follow up to our interview with Dr. James Min, CEO of Cleerly Health, we talk with two venture investors in the early heart attack risk detection company. Justin Klein, MD, of Vensana Capital walks us through the steps he took before leading the company’s recent $43 million Series B round. Tripp Peake of LRV Health explains why the company interests his venture firm’s limited partner base. This is an opportunity for entrepreneurs to better understand the venture capital due diligence process. Chris Newmarker, executive editor of life sciences, delivers his Newmarker’s Newsmakers brings top news from Conformis, Stryker, Siemens Healthineers, Abbott, Medtronic and Levita Magnetics. LIKE! FOLLOW! SUBSCRIBE! We’re on most major podcast channels.

Vicarious Surgical and CMR Surgical recently combined to raise over $1 billion from public and private investors. Big money clearly as found surgical robotics. Now what? We connect with Per Vegard Nerseth, the new CEO of CMR. Nerseth comes to CMR from the robotics industry, so he brings deep industry understanding of what it will take to get CMR to the next level. The company closed on $600 million for a Series D, which is likely the largest private medtech investment in history. Later, we reconnect with Adam Sachs, co-founder and CEO of Vicarious Surgical. Sachs walks us through the process of merging with a SPAC (not for the faint-hearted.) With over $400 million in hand, Vicarious is bringing in senior talent and moving to a legacy filled new HQ to prepare for its next stage. Chris Newmarker, executive editor of life sciences at MassDevice, brings his Newmarker's Newsmakers highlighting news from Stryker, Heartflow, Hillrom, BardyDx, TransMedics and Imperative Care. Subscribe to this podcast on every major podcast channel!

The bioelectronics industry is poised to take off so we visited with Carolina Aguilar, CEO/Co-founder, INBRAIN Neuroelectronics about the field's potential. Chris Newmarker, executive editor of life sciences at MassDevice, delivers his Newmarker's Newsmakers highlighting news from Dexcom, NeuroMetrix, Nevro, Ancora and the Galien foundation. Subscribe to this podcast on Google, Amazon, Apple, Spotify and other major podcast channels.

This week's episode focuses on new hope for people with diabetes. Brad Paddock, CEO of CeQur, explains how its "wearable pen" can deliver insulin in a better way while Sean Salmon, head of Medtronic's diabetes business, reviews that company's growing portfolio. He also gives insights on its intriguing partnership with the private equity group, Blackstone. Chris Newmarker, executive editor of life sciences, drops a weighty Newmarker's Newmakers featuring stories from Hillrom, Baxter, NeuroMetrix, Philips, Medtronic and BD. Subscribe to this podcast on all major podcast apps.

This week’s episode focuses on the entrepreneurs. We open up with an interview with Andy Doraiswamy, founder and CEO of Koya Medical, a company he founded to help find a therapy for his ailing father. Then we revisit with Dr. Todd Brinton, chief scientific officer and corporate vice president at Edwards. This interview initially ran in May 2020 but we’re playing it again to amplify the unusual path that entrepreneurs take to find success.

Let's get interventional. This week, we talk with leaders from Abbott and Cordis about their plans to advance of medtech's stablest business. Duke Rohlen, executive chair, will explain to co-host Tom Salemi why he led the purchase of Cordis from Cardinal. Meanwhile, Dr. Nick West, CMO and DVP of vascular at Abbott, updates Associated Editor Sean Whooley on the Xience pipeline. This week's Newmarker's Newsmakers brings the big news from Abbott, Heartflow, Intersect ENT, Intuitive, Medtronic, Philips, and Resmed. Subscribe to this podcast on all major podcast applications!

New therapeutic approaches require fresh perspectives, and few perspectives were as fresh as Dr. Steven Mickelsen, the developer of a potentially paradigm shifting cardiac ablation treatment – pulse field ablation. Dr. Mickelsen, a high school dropout turned musician, fell deep enough in love with electrophysiology to go back to school, obtain a medical degree, and put his inclination to tinker to work in developing a new type of ablation. In this podcast we’ll walk down the path that led Dr. Mickelsen to create Farapulse, the early pioneer in this form of energy that now belongs to Boston Scientific. Dr. Mickelsen left the company a few years ago but he’s resumed his work helping Acutus Medical bring their technology to the market. He serves as that company’s chief translational science officer. In our second talk, we connect with Dr. Kenneth Stein, senior vice president and CMO of Boston Scientific’s cardiac rhythm management business. Dr. Stein allows us to pick up where Farapulse is leaving off, explaining why Boston Scientific bought the company now and what the plans are for the ablation systems, which has CE Mark but still requires FDA approval. Dr. Stein also shares advice for those physicians who may want to join a corporation. We also bring in Medtronic’s Rebecca Seidel, president of cardiac Ablation Solutions, and Dr. Robert Kowal, vice president of medical affairs and CMO at the cardiac rhythm and heart failure business. In this excerpt from our recent MedtronicTalks Podcast, Seidel and Dr. Kowal give a quick update on that company’s pulse field ablation technology. This week’s Newmarker’s Newsmakers is delivered by Senior Editor Danielle Kirsh and Associate Editor Sean Whooley including news from Ultrahuman, Johnson & Johnson, ResMed, Abiomed, and Abbott. Subscribe to this podcast on Amazon, Apple, Google and Spotify and other leading podcast apps.

This week, DeviceTalks Weekly Podcast examines the single-use endoscope market. We’ll hear from market leaders Ambu and Boston Scientific in a replay of interviews we conducted in September 2020. Guests include Ambu’s CEO Juan Jose Gonzalez and Stephen Block as well Boston Scientific’s Endoscopy executives Dr. Brian Dunkin, chief medical officer, and Unit President David Pierce. You’re also invited to participate in a discussion led by TE Connectivity on Tuesday’s DeviceTalks Tuesday. Chris Newmarker, executive editor of life sciences at MassDevice, presents this week’s top Newmarker’s Newsmakers – Abbott, Boston Scientific, Medtronic, Johnston & Johnson, Auris and Amazon. Subscribe to this podcast on Amazon, Google, Apple, Spotify and other major apps.

Edward Lifesciences’ acquisition of Percutaneous Valve Technologies helped mark the birth of one of medtech’s great game-changers – the development of the transcatheter aortic valve replacement. In this week’s episode, Stanton Rowe, the former CEO of PVT, will walk us through the early days of TAVR, including the enormous doubt the start-up faced as it developed the technology. He also explained how Edwards came to acquire the start-up, which had strong interest from Medtronic, Boston Scientific, and others. Rowe, who is now CEO of the NXT Biomedical incubator, also offers some provocative thoughts on the origins of medtech innovation (and explains why he misses medical device conferences.) Larry Wood, corporate vice president at Edwards Lifesciences, will explain why Edwards opted to pursue PVT rather than continue to develop its own TAVR technology. He also explains why the clinical trial testing of the valve now known as Sapien was so difficult and how he rewrote the compensation packages for his TAVR sales team to help build confidence in the new technology. Scan the QR code for more information about our upcoming DeviceTalks Tuesday discussion with Sagentia! You can subscribe to this podcast on most major podcast players including Amazon, Apple, Google, and Spotify.

Zoll Medical’s acquisition of Itamar Medical is just latest sign of the opportunity diagnosing and treating sleep apnea presents to medical device companies, especially following the CPAP machine recall issued by Philips Respironics earlier this summer. This week, we’ll talk with two of the leaders in this increasingly competitive market. First, we’ll reconnect with Tim Herbert, CEO of Inspire Medical Systems, to learn how that neurostimulation company is working to serve patients seeking an alternative to CPAP machines. This is our second visit with Tim Herbert. You can find his earlier interview on DeviceTalks.com. Then we welcome Michael “Mick” Farrell, CEO of ResMed, the leading provider of CPAP machines. Farrell explains why the apnea market is growing and what this means for the future of ResMed, which has grown into other respiratory businesses. Chris Newmarker returns! The executive editor of life sciences at MassDevice presents his Newmarker’s Newsmakers including Zoll, Itamar, Medtronic, Medicrea, iRhythm, Zimmer and its new spinout, ZimVie. We also discuss CMS’s disappointing backtrack on reimbursing innovative technologies. Danielle Kirsh, senior editor of life sciences, also presents a short report on the trial of Theranos founder Elizabeth Holmes.

This episode of the DeviceTalks Weekly Podcast draws from two realities First, Russell Powers, worldwide president, shoulder reconstruction, sports medicine, and spine at DePuy Synthes details how the company’s new Inhance Shoulder system will help the company grab market share in the increasingly competitive space. Later, we meet Dr. Justin Barad, CEO of OssoVR, on his own turf, conducting an interview in OssoVR’s virtual reality training platform. In the interview, Dr. Barad demonstrates why virtual reality training help alleviate the growing demands on surgeons while also improving performance. Chris Newmarker, executive editor of life sciences, identifies this week’s Newmarker’s Newsmakers including Abbott, Medtronic, and Vicarious Surgical. Senior editor Danielle Kirsh also shares her insights on the ongoing Theranos trial, including damaging testimony from General James Mattis. Subscribe to this podcast on all major channels!

Get it? Attractive? Magnets. Yeh, we’ll, we’re tired from putting this monster podcast episode together but it’s so, so good. You’ll hear from David Fischel, CEO of Stereotaxis, a 30-plus year old medtech that’s going through a quiet but deliberate reboot. Fischel says he took the company over because Stereotaxis’ magnetic robotic surgery system makes interventional surgery safer, an assertion supported by Daniel Cooper, MD, associate professor at Washington University School of Medicine. Stereotaxis appears to be on the cusp of something big. Then, Alberto Rodriguez-Navarro, MD, tells us why he sold everything to move from his native Chile to move to Silicon Valley and start Levitra Magnetics. The company is anticipating FDA approval for its own robotic system that could help hospitals overcome staffing shortages during laparoscopic procedures. We’ll also hear our sponsor Futek explain how its miniaturized sensors are advancing robotic surgery. Chris Newmarker, executive editor of life sciences, delivers the week’s big news featuring Siemen Healthineers, LumiraDx, Boston Scientific, Abbott and Medtronic. Senior editor Danielle Kirsh updates us on the Theranos trial. Subscribe to this podcast on all major channels.

Co-hosts Tom Salemi and Chris Newmarker announce the newest member of the DeviceTalks Podcast family - IntuitiveTalks!

In this first episode of the new IntuitiveTalks Podcast, we’ll start right at the beginning. CEO Gary S. Guthart recalls how a court side basketball conversation led to his introduction to the early form of a surgical robot and convinced him to join. He also shares his expectations for the surging surgical robotics field, including how the company will view emerging competition. This episode is sponsored by Tegra Medical.

The urology specialty faces a critical moment, with 10 urologists ready to retire for every new urologist entering the field. That puts the onus on medical device companies to develop faster, safer and more efficacious ways to break down kidney stones, shrink enlarged prostates and handle other critical treatments. In this week’s episode, we’ll speak with Meghan Scanlon, SVP and president, Urology and Pelvic Health at Boston Scientific about that company’s growing pipeline bolstered by the acquisition of Lumenis. This episode was sponsored by KNF Neuberger. We’ll also connect with the leaders of Zenflow – CEO Nick Damiano and President Susan Stimson – about the start-up’s minimally invasive treatment for urinary obstruction caused by enlarged prostate, or benign prostatic hyperplasia (BPH). Finally, we have all-hands (or most hands) on deck for this episodes Newmarker's Newsmakers. Jim Hammerand, managing editor of Medical Design and Outsourcing, talks about Koya Medical and Hologic. Associate Editor Sean Whooley shares his insights on Varian and Explorer Surgical. Pharma Editor Brian Buntz gives us the latest on the never ending saga of Covid-19 booster approval. Subscribe on all major podcast applications.

The surgical robots are back in this episode of the DeviceTalks Weekly Podcast. First we’ll speak with Megan Rosengarten, president of robotics at Medtronic, about what the CE Mark for the Hugo surgical robot system means for current and future applications. Then, we speak with Ivan Tornos, COO of Zimmer Biomet, about that company’s broad technology offerings include ZBEdge, PersonaIQ Knee Implant, and other digital data collectors. Tornos says Zimmer Biomet intends to be the boldest company in the medtech industry. Chris Newmarker is back to deliver this week’s Newmarker’s Newsmakers – Intuitive Surgical, Xenter, Moderna, Medtronic, and Johnson & Johnson. Associate Editor Sean Whooley joins in on the fun. Subscribe to this podcast on all major podcast applications.

MassDevice’s Brian Johnson and CeQur's CEO Jim Peterson discuss Peterson’s personal connection to diabetes, and how that personal connection has impacted the company’s direction.

This week we’ll hear from Chris Barry, CEO of NuVasive. Barry joined NuVasive at a critical period in 2018. Now, the company is building out its portfolio of surgical tools, adding a digital surgery platform, planning its own move into robotics and finally making training much easier for its surgeons through new facilities, both real and virtual. Danielle Kirsh, senior editor, and Jim Hammerand, deliver the highlights from this month’s Medical Design and Outsourcing Magazine, our Women in Medtech issue. Danielle reveals some disheartening news about jobs and research dollars going to women while Jim shares hopeful details from some of the profiles. Chris Newmarker, executive editor, identifies this week’s Newmarker’s Newsmakers – Avail Medsystems, Integra Lifesciences, GE, Medtronic and NuVasive. Subscribe to this podcast on all major podcast applications.

In the second episode of IntuitiveTalks, two senior executives explain how the company gets surgeons and hospitals to understand the benefits of the Da Vinci system. EVP Dr. Myriam Curet, who describes herself as a late adopter of technology, shares why she opted to join Intuitive as CMO early on after trying the Da Vinci robot. Similarly, SVP Gillian Duncan, who heads physician training and development, says her early experience with the robotic system convince her to leave her academic career to join the robotics pioneer. Subscribe to this podcast on all major podcast applications.

In this week’s episode, we follow up on our first episode focused on Transcatheter Aortic Valve Replacement (TAVR). This time we speak with one of the market leaders, Medtronic, about their broad structural heart portfolio. Nina Goodheart, president of Structural Heart, walks us through each valve and explains why Medtronic is sponsoring a clinical trial pitting its aortic valve against a rival’s. We also hear from the new competitor on the block, Abbott, which recently earned FDA approval for its valve. Santosh Prabhu, PhD, introduces the new entry and explains why this work is so important to him personally.

This week’s discussion begins on the stage in Las Vegas where Tom Salemi interviewed Kwame Ulmer of Ulmer Ventures and Medtech Color at Medmarc’s annual broker meeting. This episode is sponsored by Medmarc. The conversation hit upon five areas that have changed over the past two years due to the pandemic or critical concerns over equity and fairness. In this podcast, Ulmer speaks to the slow progress being made in medtech in diversifying the workforce. But he also offers signs of hope and introduced Medtech Color. Ulmer will also speak to improvements made at the FDA, where he started his medtech career. He also provides an update on a comprehensive survey of the FDA being conducted by the biomed program at UCLA. We’ll also hear post-conference interviews with Jennifer Fried, CEO of Explorer Surgical, who will share how that company successfully pivoted during the pandemic. Mark Leahey, CEO of MDMA, will update on the MCIT ruling that would deliver surer reimbursement for medical device companies with breakthrough products. Finally, Jonathan Norris of Silicon Valley Bank shares surprising changes to early and late-stage financings as well as medical device exits. Subscribe to this podcast on all major podcast applications.

Just a short message from Tom and Chris, two grateful guys who don't like pumpkin sausage.

In this episode, we’ll do a deep dive with Stryker Corp., which recently hosted an in-person analyst day. In our first interview Andy Pierce, group president of MedSurg and Neurotechnology, will update us on his group’s wide-ranging portfolio, including an artificial intelligence-enabled tool to save the lives of patients at risk of dying of post-partem hemorrhaging. Kevin Lobo, chair and CEO, visits next to update on the company’s plans to keep building on its market leader status. We’ll talk about the Wright Medical integration, what makes a good acquisition, and how the rise of surgical robotics is helping Stryker build out its MAKO product. In between all this, co-costs Tom Salemi and Chris Newmarker review this week’s Newmarker’s Newsmakers including items from GE Healthcare, Best Buy, the FDA, DePuy Synthes and Boston Scientific. We also talk about pie.

In this episode, we learn about the data collecting during surgical robotic systems. Chief Digital Officer Brian Miller and Tony Jarc, Director, Research and Data Science , detail the importance of data being collected by Intuitive’s surgical robotic systems and how the company uses the data to help guide surgeons in the future.

In this episode we’ll explore potentially life-saving treatments for hypertension and stroke. First, we’ll talk with Sandra Saldana, CEO of the start-up Alva Health, which is developing a wearable system that can detect strokes. Alva Health won the 2021 Global Competition of the Medtech Innovator program. Then we’ll explore renal denervation, the exciting but vexing method of lowering hypertension by ablating nerves in the kidney. We’ll talk to the leaders in this space including Andy Weiss, CEO of Recor Medical, a division of Otsuka Holdings, that’s developing the Paradise Renal Denervation system. Weiss, a medtech veteran, shares his long-term views, one why he still sees Renal Denervation as a game-changer. Then, we’ll run an excerpt of the MedtronicTalks podcast interview with Jason Weidman, senior vice president and president of the coronary and renal denervation business at Medtronic. Weidman details Medtronic’s latest regulatory hiccups but, like Weiss, explains why he sees renal denervation as an important new therapy that can save the lives of people struggling to control their hypertension. You can listen to the entire interview with Weidman here. https://www.devicetalks.com/weidman-talks-us-through-the-long-road-to-get-symplicity-ready-to-help-patients-with-hypertension/.

In this episode, we’ll dive deep into the Heart Failure business at Abbott. First we’ll connect with Philip Adamson, MD, chief medical officer of the group. Dr. Adamson uses an explanation of CardioMEMS to give a vivid portrait of how patients live with heart failure. Technology, he says, makes turns those patients into their own health care workers. This podcast is sponsored by KNF. Then, we’ll talk with Kevin Bourque, vice president of research and development, and Robert Kormos, division VP, global affairs of heart failure, about the advances of Heartmate 3. Both also detail how Abbott is working to help children suffering from the condition. Dr. Kormos also shares the most gratifying part of his job. The entire editorial staff joins the podcast to share their personal top stories of 2021. News includes mentions from Vicarious Surgical, ResMed, Philips, Pfizer, BioNTech, Abbott, Dexcom and Insulet. Happy New Year!!! We'll see you in 2022. LIKE! FOLLOW! SUBSCRIBE!

Glooko CEO Rick Altinger and MassDevice's Brian Johnson discuss Glooko's mobile diabetes management app. Altinger describes the economics behind the Glooko platform, as well as the app's ability to foster easy communication between diabetes patients and healthcare providers.

Happy New Year! In this first episode of 2022, we’ll learn a lot about Olympus Corp.’s plans to expand into the medtech industry. The global behemoth has been doubling down on the industry in recent years. COO Nacho Abia and Gabriela Kaynor, global division head of therapeutic solutions in the Americas, will lay out the plans to build into other parts of the medtech industry. Chris Newmarker is back with his Newmarker’s Newsmakers! Chris will bring news from Boston Scientific, GE Healthcare, Titan Medical, Relievant Medsystems, Medtronic, Memic Innovative Surgery, and Stryker. Subscribe to catch future episodes on any major podcast player.

In this episode, two senior orthopedics executives at DePuy Synthes walk us through the company’s growing portfolio. First, Rajit Kamal, worldwide president, sports medicine and shoulder reconstruction, lays out the opportunity for the growing shoulder market and explains what the INHANCE Shoulder System offers to surgeons. He also details what it will take for ortho companies to grow the shoulder market. Later, Andrew Ekdahl, Worldwide President, Joint Reconstruction, updates us on the company’s VELYS surgical robotic system. He explains how new digital and robotic tech will change the orthopedics industry. Instead of Newmarker’s Newsmakers, this week host Tom Salemi will review the most listened to DeviceTalks Weekly Episodes of 2021. We’ll also announce upcoming news in in-person conferences, digital meetings and podcasts – including a NEW podcast powered by DeviceTalks. Subscribe to all these podcasts at most major podcast platforms.

In this week’s DeviceTalks Weekly podcast, Outset Medical’s Leslie Trigg recounts the career detour that led her to a successful career in medical devices. Drawing on past experiences, the CEO explains why she chose to lead Outset’s mission to create a dialysis system that restore the freedom lost to the demand of traditional in-clinic dialysis. Outset’s “enterprise system” for dialysis now allows patients to treat themselves at home when and where they want. Can Outset serve as a model for other “hospital at home” approaches. Chris Newmarker delivers another stellar Newmarker’s Newsmakers featuring news from the Big 100, Edwards Life Sciences, Inspire Medical, Dexcom, Medtronic, Neurometrix, Augmedics and Acutus Medical. Subscribe on all major podcast channels.

In this episode, we learn about Intuitive’s OTHER ground-breaking robot, the ION endoluminal system. This episode is sponsored by Maxon Group. ION allows for robot-assisted bronchoscopic procedures such as biopsies in the hardest to reach areas of the lung. The FDA cleared the ION system in 2019. We speak with Charlie Dean, vice president and general manager of the endoluminal business unit at Intuitive, an engineer who has spent his career working to make smaller, more effective minimally invasive tools. We also talk with Oliver Wagner, MD, vice president and medical officer of the endoluminal division. Wagner explains how his long-time pursuit of NOTES led him to join Intuitive. He also sees a future where ION can serve as a platform for many other devices. Subscribe to this podcast on every major podcast platform.

We drill down on diagnostics – including COVID-19 testing – with Dave Hickey, newly promoted executive vice president and president of the life sciences segment of BD and Brooke Story, who took over his post as worldwide president of integrated diagnostic solutions. How did BD handle the crushing demand for at-home tests and where is diagnostics headed in the future. Paul Grand, CEO of Medtech Innovator, sits in with Chris Newmarker and Tom Salemi on this week’s Newmarker’s Newsmakers. He also delivers some important deadlines for medical device startups. This week's Newsmakers include Medtronic, Edwards Lifesciences, Distal Motion, Respironics and ZimVie. Find out more about Medtech Innovator at MedtechInnovator.org. Register for DeviceTalks at devicetalks.com. Use the discount code mentioned in this episode! Subscribe to this podcast on any major podcast channel.

In this episode we’ll interview Michael Friedrich, CEO of Distalmotion, creator of Dexter, a robotic system used for laparoscopic procedures. Friedrich details how Dexter is positioned to build a market in an area untapped by other surgical robotic systems. The company recently closed on a $90 million Series E led by Revival Healthcare and 415 Capital. (For a related podcast listen to our most recent episode of Intuitive Talks on your DeviceTalks Weekly Library.) Executive editor Chris Newsmaker delivers his Newsmaker’s Newsmakers – Boston Scientific, Medtronic, BD, Hologic and Senseonics. Find out how these companies are tied to the upcoming DeviceTalks Boston meeting and listen for the discount code. Subscribe to this podcast!

This week we’ll focus on a few of the exciting companies in the diabetes space. Associate Editor Sean Whooley first tracks down Dexcom CEO Kevin Sayer, who discusses the company’s next-generation G7 continuous glucose monitor, which is awaiting FDA approval. Then, Sean speaks with Bigfoot Biomedical CEO Jeffrey Brewer to learn more about what he calls “a transformational attempt” to simplify CGMs with an all-in-one platform with a smart insulin pen cap. Finally, Sean interviews Senseonics CMO Dr. Francine Kaufman about the company’s Eversense 180-day CGM, which just received FDA approval. Chris Newmarker brings his Newsmakers of the week including Amazon, Thermo Fisher, HeartFlow, Abbott, Cooper Company and Cook Medical. This episode was sponsored by Accumold. Subscribe to this podcast on major podcast channels.

Welcome to the first ever DeviceTalks Weekly Pitchcast! This week Kwame Ulmer, executive director of Medtech Color, sits in on the Newsmaker segment and delivers details on the upcoming Medtech Color Pitch Contest. Then, you can hear from the contests finalists themselves - AllergenIQ, bTECH LLC, Candlelit Therapy, Dialysis-X, Diatech Diabetes, Free From Marketplace, SealCath, Sunny and TAB Diagnostics. You can watch the pitch competition on March 8 by registering at MedtechColor.org. Chris Newmarker's Newsmakers includes Philips, Boston Scientific, Bayliss, Johnson & Johnson, DePuy Synthes and Masimo. Subscribe to this podcast on every major podcast channel.

In this episode, we’ll speak with Heather Hudnut Page, vice president and general manager of peripheral vascular at Philips about the company’s ongoing efforts to build an image-guided therapy program. Hudnut Page will walk us through the four sizable acquisitions Philips has made to build out its pipeline. We first visited Philips two years ago when we spoke with Chris Landon, Senior Vice President and Business Leader for Image-guided therapy devices. Chris Landon returns to the podcast to share his thoughts on this week’s Newsmarker’s Newsmakers. This week, Executive Editor Chris Newmarker highlighted the news from Baxter, Shockwave, Smith & Nephew, Medtronic, and Abbott. Subscribe to this podcast on any major podcast channel. You can listen to Chris Landon's interview here. https://www.devicetalks.com/philips-imaged-guided-leader-landon-shares-global-giants-plans-for-minimally-invasive-devices/

In this week’s episode of the DeviceTalks Weekly Podcast, Vafa Jamali, CEO of the newest medical device company ZimVie, speaks with Chris Newmarker, executive editor at MassDevice, about the companys’ plans post-spinout from Zimmer Biomet. Jamali explains where the company sees opportunities to compete in the spinal space. In addition to the interview, we talk about the medical device industry’s support of Ukraine, as it’s being invaded by Russia. If you want to support Ukrainians during this attack you can find some charities here. https://www.forbes.com/advisor/personal-finance/donate-relief-to-ukraine/ In our Newmarker’s Newsmaker’s segment we hit about news from Siemens Healthineers, Roche, Philips, Varian, Heartflow, and Butterfly Networks. If you want to see the agenda for DeviceTalks Boston go here. https://boston.devicetalks.com/ If you want to register for my webinar discussing our plans for our in-person DeviceTalks Boston meeting go here. https://gateway.on24.com/wcc/eh/2927718/lp/3691568/were-back-an-insiders-look-into-bringing-back-a-better-devicetalks-boston

In this week’s podcast, we’ll speak with Sally Saba, MD, Medtronic’s chief inclusion and diversity officer, about the company’s work to create a more welcoming – and better performing – workplace. Paul Grand, CEO of MedTech Innovator, returns to take part in Executive Editor’s Chris Newmarker’s Newsmaker session. We talk about hour industry’s response to Russia’s invasion of Ukraine, Ryan Egeland, MD, joining Big Sky Innovator, the top-performing companies of 2021, the collapse of another SPAC deal, and an eye-opening approval. https://www.medicaldesignandoutsourcing.com/how-medtech-and-pharma-are-responding-to-russias-invasion-of-ukraine/ https://www.massdevice.com/former-cardiovascular-systems-chief-medical-officer-joins-big-sky-biomedical-incubator/ https://www.massdevice.com/these-10-medtech-companies-stocks-performed-best-in-2021/ https://www.massdevice.com/memic-innovative-surgerys-spac-deal-is-off/ https://www.massdevice.com/alcon-launches-clareon-intraocular-lens-in-u-s/ BUY A MAMMOTH TOOTH FOR A GOOD CAUSE - https://www.newburyportnews.com/news/mammoth-find-for-gigantic-ukrainian-cause/article_bed30a28-a093-11ec-a3a2-370b99bd241b.html LEARN ABOUT DEVICETALKS BOSTON https://gateway.on24.com/wcc/eh/2927718/lp/3691568/were-back-an-insiders-look-into-bringing-back-a-better-devicetalks-boston SIGN UP to try to present at DeviceTalks Boston though the MedTech Innovator Program https://medtechinnovator.org/apply/

In this debut episode of the StrykerTalks Podcast series, Spencer Stiles, group president of orthopaedics and spine business at the medical device giant, reveals the mixture of art and science that went into successfully integrating Wright Medical into Stryker’s industry leading orthopedic business. What does Wright’s portfolio and personnel bring to the table? We’ll also talk about MAKO’s future. How will robotic surgery fit into healthcare delivery more broadly, and what does new complementary tech make possible.

In this episode, we talk to two principals of Johnson & Johnson MedTech’s push to bring higher powered tech into its digital surgery strategy. In separate interviews, Johnson & Johnson Group CIO and Global VP of Medical Devices Larry Jones and Office of Digital Innovation Leader Peter Schulam (who also serves as global head of medical affairs, clinical affairs and pre-clinical research for Johnson & Johnson Medical Devices Cos.) explain how the company is moving toward the future. In our Newmarker’s Newsmakers segment, Jim Hammerand, managing editor of Medical Design and Outsourcing, tells us about his ongoing Cloud series. We first heard from Jones and Schulam in an MDO article. Link below. Jim also joins Chris Newmarker, executive editor of life sciences, and Tom Salemi, Editorial Director of DeviceTalks, in discussing medtech’s news of the week including news from robotic pill maker EndiaTx, Johnson & Johnson, Medtronic, DexCom and GE Healthcare and AliveCor. Also, listen for the code to save 25% off registration to DeviceTalks Boston and DeviceTalks Minnesota. TODAYS LINKS MDO Article - https://www.medicaldesignandoutsourcing.com/johnson-jnj-microsoft-cloud-larry-jones-peter-schulam/ Newsmaker #5 - https://www.medicaldesignandoutsourcing.com/endiatx-pillbot-stomach-cam-swims-torrey-smith/ Newsmaker #4 - https://www.massdevice.com/johnson-johnson-medical-devices-rebrand-medtech-jnj-name-change/ Newsmaker #3 - https://www.massdevice.com/medtronic-names-new-presidents-for-diabetes-surgical-robotics-cardiac-rhythm-units/ Newsmaker #2 - https://www.drugdeliverybusiness.com/dexcom-wins-ce-mark-for-next-gen-g7-cgm-will-begin-european-launch-within-weeks/ Newsmaker #1 - https://www.massdevice.com/ge-healthcare-alivecor-partner-to-reduce-cardiac-related-hospitalizations/ Donate to World Central Kitchen - https://wck.org/ Subscribe on all major podcast channels.

In this episode of the DeviceTalks Weekly Podcast, we speak with Yuriy Lebed, the CEO of Pharmaxi LLC, a CRO based in Kyiv, Urkaine, that works with pharmaceutical and medical device companies across the globe. In an interview from Lviv, Lebed says he was as shocked as many that Russia would invade its neighbor. The attack forced him to relocate with his family to Lviv, in the western part of the country. From there, he’s been able to lead the CRO as it keeps many clinical trials running. He calls the country’s regulators are “heroes” for vowing to process approvals while the capital city is bombed. He also says Pharmaxi is already planning for the future, which includes expanding operations into Poland and working within EU countries. You can find a way to donate to relief efforts for Ukraine here. https://www.forbes.com/advisor/personal-finance/donate-relief-to-ukraine

In this episode of IntuitiveTalks, we take our first look at Intuitive’s Future Forward program, a three-piece initiative to better understand how the company fits best into an evolving healthcare landscale. Our guests are Julian Nikolchev, an experienced medical device entrepreneur and investor who now serves as SVP, Development and Strategy at the Intuitive. Nikolchev led the creation of Intuitive Ventures, a $100 million corporate venture capital program led by our second guest, Oliver Keown, MD, a physician turned investor who is leading the creation of an intriguing portfolio of digital and medical device companies that will help inform Intuitive’s future. You can see Intuitive’s full team and portfolio here. https://ventures.intuitive.com/

In this episode, we’ll assemble the news team to bring you stories big, small and in the middle. Associate Editor Sean Whooley delivers HUGE results. He interviews CEO Dev Kurdikar and CFO Jake Elguicze, leaders of the newly spun out Embecta, the one-time business of Becton Dickinson that’s now an immediate player in the diabetes space. Later on, Jim Hammerand, managing editor of Medical Design & Outsourcing magazine, interviews Torrey Smith, the CEO and Co-founder of Endiatx, a small company developing microrobots that could someday replace the work of an endoscope. In between we’ll hear the Newmarker’s Newsmakers from Chris Newmarker, executive editor of life sciences. This week’s top stories including new from Philips, Biobeat, Staar Surgical, BD, Embecta and Owens Minor. Find the articles here: https://www.massdevice.com/government-warns-on-cybersecurity-issues-with-philips-e-alert-mri-monitoring-system/ https://www.massdevice.com/fda-clears-biobeats-remote-vital-sign-monitoring-system/ https://www.massdevice.com/staar-surgical-wins-fda-approval-for-evo-visian-implantable-collamer-lens/ https://www.massdevice.com/bd-completes-spinoff-of-embecta-diabetes-company/ https://www.massdevice.com/owens-minor-completes-1-6b-acquisition-of-apria/ To read Jim Hammerand's Medical Design and Outsourcing cover story on Endiatx go here. https://www.medicaldesignandoutsourcing.com/endiatx-pillbot-stomach-cam-swims-torrey-smith/ Subscribe on all major podcast apps.

In this episode, Penumbra CEO Adam Elsesser shares why he left a successful law career to become CEO of a medical device startup. After selling that company to Boston Scientific, Elsesser and his co-founders started Penumbra, which has steadily built businesses in stroke and vascular businesses. But Penumbra’s biggest business may be an immersive VR technology system that’s able to improve mental health. This episode is sponsored by TE Connectivity. Executive Editor Chris Newmarker brings his top stories of the week. This episode’s Newmarker’s Newsmakers including Ascensia, Senseonics, GE Healthcare, Olympus, DJO, Abbott. We also highlight the biggest news of the quarter coming, including an acquisition by Medtronic. Subscribe to this podcast on any major podcast player.

In this episode of StrykerTalks, Jessica Mathieson, vice president and general manager of the Acute Care, recounts her unusual path into the medical device industry, giving advice to others interested in making the transition. The conversation then delves into an unassuming – but critical – piece of medical equipment – the hospital bed where most patient-healthcare interaction takes place. Later in the interview, Mathieson will talk about Stryker’s work to provide new technologies that help healthcare workers handle their increasing stress loads; technologies that incorporate technology from the recently acquired Vocera. Also, how is Stryker sharing risk with hospitals to increase patient safety?

In this week’s episode, we interview Joe Army, CEO of Vapotherm, and Alton Shader, CEO of Viant. First. We’ll follow Army’s heartful move into Medtech, which includes his current role as CEO of Vapotherm, maker of the high flow nasal cannula that proved to be a highly effective tool to treat patients hospitalized with COVID-19. We’ll later learn that Vapotherm’s ability to supply hospitals with this life-saving technology was in doubt due to labor shortages. But Shader details how the contract manufacturer stepped in to immediately help with Vapotherm’s dilemma. The interview is a taste of the discussion Vapotherm and Viant will lead at DeviceTalks Boston on May 10. Go to devicetalks.com to register. We also bring in former Johnson & Johnson executive Peter Stebbins to tell us about his upcoming interview with Frank Doyle III, dean of Harvard’s John A. Paulson School of Engineering and Applied Sciences. Doyle will be our keynote interview subject on the morning of May 10 at DeviceTalks Boston. Stebbins also provides his experience and insights to this week’s Newmarker’s Newsmakers including news from Medtronic, Masimo, Boston Scientific, GE Healthcare and FitBit. #5 https://www.medicaldesignandoutsourcing.com/medtronics-ceo-would-like-to-put-the-tech-in-medtech/ #4 https://www.massdevice.com/masimo-completes-acquisition-of-sound-united/ #3 https://www.massdevice.com/boston-scientific-wins-fda-approval-for-imaged-guided-software-for-dbs-therapy/ #2 https://www.massdevice.com/ge-healthcare-elekta-collaborate-to-expand-precision-radiation-therapy-access/ #1 https://www.massdevice.com/fda-clears-fitbit-ppg-algorithm-to-detect-afib/

In this episode, we’ll talk to two of the more innovative companies in the peripheral vascular space – Shockwave Medical and LimFlow – about how they’re helping to treat people who previously had few or zero options. This episode is brought to you by Confluent Medical. LimFlow CEO Dan Rose walked us through his decision to build his Medtech career in Europe. He also talked about LimFlow’s unique approach to using veins as a route to deliver blood to limbs rather than return blood to the heart. Our second interview is with Doug Godshall, CEO and President of Shockwave Medical. Godshall admittedly came to medtech later in his career, but he’s taken on some of its most serious and intractable problems, first as CEO of HeartWare and now Shockwave Medical. You can learn more about Shockwave here https://shockwavemedical.com/about/our-story/ and LimFlow here. https://limflow.com/ We’ll also have Chris Newmarker delivering his Newmarker’s Newsmakers including news from Philips, Johnson & Johnson MedTech, Natus Medical, Amazon Web Services, and Dentsplay Sirona. Subscribe to this podcast on all major podcast apps. #5 https://www.massdevice.com/philips-has-another-round-of-serious-ventilator-recalls/ #4 https://www.massdevice.com/johnson-johnson-medtech-is-shopping-for-ma-deals/ #3 https://www.massdevice.com/archimed-group-to-acquire-natus-medical-for-1-2b/ #2 https://www.medicaldesignandoutsourcing.com/amazon-web-services-aws-cloud-chief-medical-officer-taha-kass-hout-machine-learning-ai/ #1 https://www.massdevice.com/dentsply-sirona-sacks-ceo/

In this episode, Nick Spadea-Anello, Boston Scientific’s global president of electrophysiology, will explain how the $1.7 billion paid for Baylis Medical will help expand the Boston's extensive EP portfolio. We also talk about the message he likes to impart upon employees of recently acquired companies, sharing some lessons he learned when Boston Scientific acquired his then-employer, Guidant. We also welcome Brian Johnson, president of MassMedic, the top medical device association in New England, into the booth as our co-host. Johnson, of course, brings his insider perspective to Newmarker’s Newsmakers, but he also shares how everyone needs to do a better job of sharing medtech’s stories. He should know. Johnson is the co-founder of MassDevice and DeviceTalks! So we got an origin story as well. Executive editor Chris Newmarker brought a powerful newsmaker list including an interesting take on a recent collaboration between Medtronic and GE Healthcare. Other newsmakers include Alcon, Philips, Abbott, and the deal between Medtronic and Acutus medical that might be an answer to Boston’s acquisition of Bayliss. 5 - https://www.massdevice.com/alcon-smartcataract-study-shows-enhanced-time-savings-during-cataract-surgery/ 4- https://www.medicaldesignandoutsourcing.com/doj-subpoenas-philips-over-respironics-recall-ceo-addresses-investigation/ 3 - https://www.massdevice.com/abbott-launches-upgraded-digital-health-app-for-neurostimulation/ More Abbott news today... https://www.massdevice.com/abbott-announces-u-s-launch-of-amplatzer-steerable-delivery-sheath-for-amulet-device/ 2 - https://www.massdevice.com/ge-healthcare-medtronic-to-collaborate-on-improving-outpatient-care/ 1 - https://www.massdevice.com/acutus-medical-sells-left-heart-access-portfolio-to-medtronic-in-50m-deal/

DeviceTalks Boston is here! Win a free registration. In this week’s episode, we’ll give you a little taste of what you’ll see at the Boston Convention & Exhibition Center on May 10-11. Friend and colleague Steve Crowe, editorial director of the Healthcare Robotics Engineering Forum, will share what attendees will see at that meeting, which is co-located with DeviceTalks Boston. Then, we’ll talk with Peter Stebbins about his Opening Keynote Interview with medtech veteran Peter Doyle, who is now dean of Harvard John A. Paulson School of Engineering and Applied Sciences. We’ll also get a final update from Paul Grand, CEO of Medtech Innovator, about the 22 mid-stage medical device companies that will be presenting at DeviceTalks Boston. A selected few will then compete at Medtech Innovator’s Pitch Contest on May 11. And to demonstrate we’re not just selling you on an event, we talk with Dave Evans, co-founder and CEO of Fictiv, a technology company that has raised nearly $200 million to fix – or disrupt – the supply chain. Finally, a contest for loyal and attentive DeviceTalks Weekly Podcast listeners. Win free registration to DeviceTalks Boston!

First, a quick recap of DeviceTalks Boston. Then, a MedtronicTalks Podcast Replay, in which Austin L. Chiang, MD, explains why he brought his sizable social media following to Medtronic, where he serves as chief medical officer of the Gastrointestinal business. Chiang says his decision is directly tied to his excitement about Medtronic’s growing suite of GI products including the AI-powered GI Genius and the swallowable PillCam. Chiang explains why he chose to couple the company’s broad platform with his own social media presence to reach more patients who may need treatment of gastrointestinal care. He also gives advice to other physicians who may want to amplify their own voices through social media.

In this episode the MassDevice editorial team will break down all the action at DeviceTalks Boston. You’ll also hear from keynote speaker Eric Benjamin, executive vice president of innovation, strategy and digital products, at the company. To read MassDevice’s coverage of DeviceTalks Boston go here. https://www.massdevice.com/tag/devicetalks-boston/ Thank you to our sponsor DeepDyve. To try out DeepDyve go to https://get.deepdyve.com/devicetalks/

Message from co-host Tom Salemi, editorial director of DeviceTalks. Check out MedtronicTalks and StrykerTalks at DeviceTalks.com. You can also subscribe to MedtronicTalks on any podcast player.

Parenthood changes everyone, but Mark Paul’s life took a drastically different turn the moment his oldest child was born. Paul discovered he had a passion for the OR and patient treatment, a realization that convinced him to switch careers to the medical device industry. Today, Paul leads Stryker’s neurovascular business which, he says, contains the origins of the stroke treatment industry. In this interview, Paul reviews the strength and strategies of the “micro plumbers” who are helping people who are at risk of suffering a stroke or are trying to find their way back. This episode is sponsored by Resonetics.

In this episode, we’ll take a deeper look into our Newmarker’s Newsmakers with Andrew Jay, general partner at the Borna Health Fund, a hedge fund that invests in medical technology companies. We’ll take about Stryker’s recent regulatory success; Quidel’s game-changing acquisition; Medtronic’s dialysis deal with DaVita and shareholder votes against executive pay at Masimo. We’ll also take a deeper look into the swirling speculation that Johnson & Johnson could look to buy Boston Scientific. In the second half of the show, we’ll run our latest MedtronicTalks podcast episode that highlighted the work the company and industry is doing to identify and combat healthcare inequity. Finally, we’ll also hear some helpful advice on cybersecurity. #5. https://www.massdevice.com/strykers-spine-guidance-software-fda-clearance/ #4 https://www.massdevice.com/quidel-ortho-clinical-diagnostics-combine/ #3 https://www.massdevice.com/medtronic-davita-kidney-device-company/ #2 https://www.massdevice.com/masimo-no-vote-executive-pay/ #1 https://www.drugdeliverybusiness.com/dexcom-quashes-insulet-merger/ https://www.massdevice.com/will-johnson-johnson-buy-boston-scientific/ Subscribe on any major podcast channel.

This week listeners will get to hear how Stryker is incorporating Vocera, Gauss and other tech into its DRE strategy. We’ll get a visit from fellow podcaster Keith Figlioli of LRV Health to talk about Oracle’s acquisition of Cerner. And Chris “WorkLord” Newmarker brings a star-studded Newmarker’s Newsmakers feature Smith & Nephew, GE Healthcare, Ethicon, Medtronic, and Moon Surgical. Thank you to Flexan for sponsoring this episode! Go to Flexan.com. Newmarker’s Newsmakers 5. Smith & Nephew makes historic move? https://www.massdevice.com/smithnephew-moving-out-of-hull-uk/ 4.GE Healthcare keeps making news! https://www.massdevice.com/ge-healthcare-workload-management-software-radiologists/ 3. Have you seen Ethicon's stapler? https://www.massdevice.com/ethicon-launches-next-gen-surgical-stapler/ 2. Medtronic adds more Neuromed Knowhow https://www.massdevice.com/medtronic-announces-new-chief-medical-officer-for-neuromodulation-unit/ 1. Moon launches robotic surgery bid https://www.massdevice.com/moon-surgical-raises-31m-robotic-surgery-system/

In this episode, Michael Matson, analyst at Needham, explains his thoughts behind a possible J&J acquisition of Boston Scientific. He also explains why he downgraded Medtronic and his take on supply chain issues. The rest of the episode will focus on Moon Surgical, which recently closed on a $31 million Series A to build a new robot that could lend critical assistance to surgeons. We speak with CEO Ann Osdoit about the company’s plans as well as investor and advisor Steve Oesterle, formerly of Medtronic. Oesterle also gives his assessment of the broader medical device-technology convergence including some fascinating forecasts for Verily. This episode is sponsored by KNF. Also hear more information about our upcoming DeviceTalks Tuesdays session and DeviceTalks West in-person meeting.

In this week’s episode, Cala Health CEO Renee Ryan joins us in the Newmarker’s Newsmaker’s booth to share her insights on the news of the week including an interesting meeting with Mike Mahoney before he become CEO of Boston Scientific. Ryan also shares details on the growing success of the Cala Trio, a device worn on the wrist to help control essential tremors. We dive deep into Cala’s story, talking with Deanna Harshbarger, vice president, product, and Doug Biehn, chief commercial officer. This episode is sponsored by AcuityMD. Executive Editor Chris Newmarker returns with his Newmarker’s Newsmakers – GE Healthcare, Boston Scientific, Ekso Bionic, Medtronic and Abbott.

In this episode, Boston Scientific CEO Michael Mahoney makes his DeviceTalks Weekly Podcast debut. In this jam-packed interview, Mahoney walks us through the cultural changes Boston Scientific has made since he joined the company a decade ago. He explains how restructuring has helped to identify leaders rather than managers. How Boston Scientific encourages people to take risks. Where does Boston Scientific see growth in markets and technologies. (We ask if Boston needs a surgical robotics platform.) Mahoney also explains how Boston Scientific knows when to let an opportunity go. We talk about experiences from his own career that others can take us lessons. Mahoney also explains what co-founder Pete Nicholas, who passed away recently, meant to the company, and what Boston Scientific will look like in five years. How will Boston Scientific move forward if the economy weakens. This episode is sponsored by PSN Labs. Executive editor Chris Newmarker brings his #NewmarkersNewsmakers – Cardinal Health, Acutus Medical, Medtronic and Boston Scientific. We also walk through a list of Medical Device companies are responding to the SCOTUS’s overturning Roe v. Wade and what this might mean for healthcare care data collection.

In this episode of IntuitiveTalks, Jonathan Conta, vice president of product management, shares Intuitive’s vision for its da Vinci SP system, a single-port system. Rather than using four arms outside the body that require multiple ports, da Vinci SP can create triangulation inside the body. Intuitive has secured broad approval for the system in Korea, but broader US approval has been coming slowly. The company is working with surgeon customers and internal engineering teams to find the right fit for da Vinci SP. The episode is sponsored by Biomerics.

In this episode, Camille Chang Gilmore, vice president, human resources and global chief diversity officer, explains why she accepted Boston Scientific CEO Mike Mahoney’s offer to help lead the company’s diversity and inclusion efforts. This company’s work led to the creation of multiple programs promoting equity and combatting racism, earning Boston Scientific multiple awards and recognition from outside the company. She also shares as personal memory that speaks to the success she’s seen. This episode is brought to you by KNF. In this week’s Newmarker’s Newsmakers, Executive Editor Chris Newmarker brings a bounty of big news items from Synchron, Amazon, Intuitive, J&J and iRhythm.

In this episode, Tom O’Brien, Ethicon’s worldwide president of endomechanical, gives a detailed lesson on the design of its Echelon 3000 surgical stapler, from recognizing the huge problem of surgical complications and identifying how to build a stapler that’s more suited to ALL surgeons. The Echelon 3000 is designed with 39% greater jaw aperture and a 27% greater articulation span, as well as software that provides real-time haptic and audible device feedback to help enable surgeons to make critical adjustments during procedures. Executive Editor Life Sciences Chris Newmarker conducts that interview and brings his Newmarker’s Newsmakers hitting upon news from Stryker, Pear Therapeutics, Dexcom and 3M. We also talk about the world’s largest orthopedics companies (find the list here https://www.massdevice.com/10-largest-orthopedic-device-companies-in-the-world-2022/) and the current spate of disappointing earnings reports from medical device companies If you’re interested in learning more about our upcoming DeviceTalks West event, join Editorial Director Tom Salemi on this short webinar. https://event.on24.com/wcc/r/3878353/5BD2F587B74A5106D4FFC61E92BC6354 Subscribe on all major podcast players.

In this replay of the popular MedtronicTalks podcast episode, Greg Smith brought decades of supply chain experience with him when he joined Medtronic last year during the throes of pandemic-induced pressures on supply chain. Over that time, Smith has been working with company leaders and outside suppliers to mitigate the challenges being wrought by the string of global crises. In this episode, we’ll learn how Medtronic is working to build a stronger supply chain that will allow it to build an inventory capable of keeping critical medical devices flowing to customers. This podcast is sponsored by Donatelle.

In this replay of our most recent MedtronicTalks episode, Dr. Laura Mauri shares the career path that started with an early interest in medicine brought, at least partly, by her mother’s cancer diagnosis. Mauri directed that interest in caring for patients – and an innate ability to keep cool under pressure – to become an interventional cardiologist, a career that led her to appreciate the benefits of new technologies. This interest in new devices drew her to join Medtronic in 2018. This year, she was named senior vice president and chief scientific, medical and regulatory officer. We’ll talk with her about the “good surprises’ she encountered at Medtronic as well as the impact that the pandemic’s fallout will have on clinical trials and clinical workflow going forward. This episode is sponsored by Medmarc insurance Group.

In this episode of the DeviceTalks Weekly Podcast, we collect three very different perspectives on what it takes to find jobs/employees in this current labor market. First, we connect with Joe McClung, president of Floodgate Medical, an executive search firm focused on the medical device industry, for an overview of the current market and some tips for job seekers. (Floodgate also sponsored this episode.) Next, Emma Plouffe, vice president of people and culture at Vicarious Surgical, tells us some of the tools she’s using to find talent for the fast-growing surgical robotics company. Then, we end the episode connecting with Elizabeth Steele, vice president of Microspec Corp., a contract manufacturing business that’s making a bold move to find and retain new employees. Of course, Chris Newmarker, executive editor of MassDevice, brings his Newmarkers Newsmakers – BD, GE Healthcare, AliveCor and Philips Respironics. Please subscribe on all major podcast players. Thanks for listening to DeviceTalks Weekly.

In this episode, Mike Panos, president of the trauma and extremities division, explains how Stryker built a powerhouse in their shoulder and foot and ankle businesses through internal development and the acquisition of Wright Medical. The purchase brought Stryker a new line of products and a virtual planning tool called Blueprint. We also explore the trauma business, including where Stryker sees opportunities for innovation and growth. This episode is sponsored by Tecomet. Please subscribe to this podcast on every major podcast player Thank you for listening to the StrykerTalks Podcast.

In this episode, two newer players to the surgical robotics space explain how they’re planning to grab their appropriate slice of the growing market. First, we’ll talk with Kurt Azarbarzin, CEO of EndoQuest Robotics, which is developing the world’s first endoluminal robotic surgical system that can access the body through the mouth or anus. In our second interview, Dvir Cohen, CEO of Momentis Surgical, shares the benefit of the Anovo System, which is indicated for use in robotic-assisted transvaginal benign surgical procedures. Chris Newmarker brings his Newmarkers Newsmakers including news from Abbott, Teleflex, Medtronic as well as special reports on neural implants and surgical robotics. You can find them both on MassDevice.com. But here’s the link to the surgical robotics article. https://www.massdevice.com/16-surgical-robotics-companies-you-need-to-know/ Thanks for listening to DeviceTalks Weekly.

In this episode, two senior leaders from Medtronic’s Cardiovascular Diagnostics & Services group share the group’s vision of “turning data into the right therapy.” Sanjiv Arora, vice president of business development and strategy, and Leo Rapallini, vice president of research & development, explain how trail-blazing technologies like the LINQ family of ICMs are a great tool in measuring infrequent – but important - cardiac events. But the company sees an opportunity to employ these tiny implantable data-collection devices to provide data that might enable doctors to predict problems before they come, both in cardiac care and other areas as part of a broader disease management strategy. This episode was sponsored by Isometric. To listen to the earlier episode featuring Julie Brewer, president, Cardiovascular Diagnostics and Services go here. https://news.medtronic.com/medtronictalks-podcast-julie-brewer

In this episode, Eileen Buckley, vice president, corporate responsibility, unpacks how Stryker is following its environmental, social and governance strategies to encourage its employees, suppliers and even customers to meet increased demands for greater healthcare access and a smaller environmental impact. In a time where employees look to work with companies that carry a broader social mission, Buckley says Stryker sees real business benefits by answering the call issued by societal stakeholders as well as its shareholders. This episode is sponsored by Dassault Systemes. Thank you for listening to the StrykerTalks Podcast. Subscribe to the DeviceTalks Podcast Network on any major podcast application including Amazon, Apple, Spotify and Google.

Nearly 700,000 people die from heart disease, that’s one out of every five deaths, a startling number that could be curtailed with better predictive tools. In this episode, we’ll talk with two medical device companies employing new analytical tools to get a clearer picture of heart health. We’ll first connect with Campbell Rogers, MD, executive vice president and chief medical officer of HeartFlow, who will explain how the company’s HeartFlow FFRCT Analysis tool can bring new data to bear. Then, we’ll connect with James Min, MD, co-founder and CEO of Cleerly, a start-up employing artificial intelligence and other tools that he says will help dispel the mystery of this elusive killer.

Not sure why but last week's podcasts didn't immediately find their way to some podcast players. They are there now, so enjoy! And thanks for listening.

The medical device industry obviously isn’t immune to the challenges posed by a shaky supply chain. But OEM leaders like Boston Scientific need to work doubly hard to ensure they have the supplies needed to provide devices for patient care. In this episode, we’ll talk with Brad Sorenson, executive vice president, Global Operations, and Paudie O’Connor, senior vice president of supply chain, to learn how Boston Scientific has managed the crisis. Topics we cover include supplier relationships, the value (and risk) of redundancies, how to reducing shipping costs and other critical topics. Supply chain executives at OEMs and smaller vendors will value from the conversation. Thanks to Paxxus for sponsoring this episode. Chris Newmarker also returns to share his Newmarkers Newsmakers – Edwards Lifesciences, Verily, Johnson & Johnson, Smith+ Nephew, and MassDevice’s Big 100! Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe on any major podcast player.

This episode of the DeviceTalks Weekly podcast features a panel discussion I led at Medmarc’s Annual Broker meeting. There are enormous insights on how investors and start-up executives see the opportunities and challenging facing the sector today. Below, you can see time stamps for each of the major topics we covered. We suggest sitting back and listening to the entire podcast – long, but not crazy long – but refer to the time stamps if you’d like to go back and listen again. Thanks to MedMarc for sponsoring! Here is the panel Ali Behbahani, MD, General Partner, NEA Ryan Drant, Founder, Managing Partner, Questa Capital Justin Klein, MD, JD, Vensana Capital Martha Shadan, Medtech CEO, Board Member Here are the topics 3:30 - Intros 8:20 - Concerns about inflation 23:20 – Optimistic or pessimistic about the future 29:20 – Regulatory/Reimbursement 43:00 – Connected Health 51:00 – Opportunities and risks of AI 58:30 – Finding a workforce 1:04:30 – Where have all the VCs gone?! Thanks for listening to the DeviceTalks Weekly Podcast

In this week’s episode, we’ll talk with leaders from Zimmer Biomet and Vicarious Surgical about the new partners they’ve entered into with national hospital companies in a bid to further their digital and robotics surgery offerings. Guests include Robert Kraal, Vice President and General Manager, Connected Health at Zimmer Biomet, and Adam Sachs, co-founder and CEO of Vicarious Surgical. You’ll get great background on both companies. One note: Tom Salemi interviewed Sachs during a DeviceTalks Tuesday Webinar. So if you’d rather watch the interview go to DeviceTalks.com where you can find the discussion – complete with video and PowerPoint presentation – available for free. Thanks to Cirtronics for sponsoring! Chris Newmarker, executive editor of life sciences, also returns with his Newmarker’s Newsmakers – Stryker, Smith + Nephew, Medtronic, Johnson & Johnson, and Philips. Thanks for listening to the DeviceTalks Weekly Podcast.

In this episode, we’ll first hear from Swarna Alcorn, business unit vice president, Olympus America, about that company’s long held – and growing -position in respiratory tools. We’ll weight the value between reusable and single-use bronchoscopes as well as the dire need for more awareness of lung cancer. Then we’ll connect with Rebecca Whitney, global spine president at ZimVie, the recent spinout of Zimmer Biomet. Whitney recounts why she joined the spinout and where ZimVie is making progress with payers. This episode was sponsored by DeviceTalks West. Thank you for listening to the DeviceTalks Weekly Podcast.

Editorial Director Tom Salemi provides a sneak peek (listen?) into next week’s DeviceTalks West conference which will be held Oct. 19-20 at the Santa Clara Convention Center. Tom will run through some of the highlights of the agenda which can be viewed at west.devicetalks.com. We also include snippets of past interviews of two keynotes – Gary Guthart, CEO of Intuitive, and Leslie Trigg, CEO of Outset Medical – from past interviews with DeviceTalks. You can find both interviews on DeviceTalks.com. If you’re interested in attending connect with Tom Salemi on LinkedIn. Thanks for listening to the DeviceTalks Weekly Podcast. DeviceTalks Weekly is available on every major podcast player.

In this episode we’ll talk with Kathryn Rieger, PhD, senior director, human factors and user research at Intuitive, about how the surgical robotics leader is working with surgeons to understand how to make its surgical systems easier to use or, for lack of a better word, intuitive. Where should buttons go. What does the blue blinking light mean? And should surgical robotics systems follow a similar template to make it easier for surgeons to master different systems. Thanks to Elsner Engineering Works for sponsoring this episode. Thanks for listening to the IntuitiveTalks Podcast. Subscribe to the DeviceTalks Podcast network to receive future episodes of IntuitiveTalks, StrykerTalks and our flagship DeviceTalks Podcast Weekly.

Just a short visit today. Paul Grand of the Medtech Innovator introduces us the five finalists of his start-up program. They’ll compete for the top spot at AdvaMed’s meeting next week. in Boston. Remember to join us at DeviceTalks West THIS week. Register at DeviceTalks.com.

In this week’s episode, we’ll visit with CL Tian, co-founder and CEO of Phiex Technologies, Medtech Innovator’s 2022 Grand Prize winner chosen by attendees at this week’s AdvaMed conference in Boston. Tian details the pending problems facing the medtech industry due to concerns about current sterilization practices and shares how Phiex could help alleviate the problem. At the start of the episode, co-hosts Tom Salemi and Chris Newmarker are joined by Associated Editor Sean Whooley and Pharma Editor Brian Buntz to revisit the high points of last week’s DeviceTalks West conference in Santa Clara. Thanks to all of our speakers, sponsors and attendees! To read the report mentioned in the podcast go here. https://www.bcg.com/publications/2022/us-ahead-in-medtech-regulation You can find ongoing coverage at MassDevice. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to this podcast on every major podcast player.

In this podcast we’ll talk with Chris Hartman, president, epilepsy, LivaNova, about how the company is developing new tools to use the vagus nerve to limit the impact of epilepsy. We’ll also hear from one of our DeviceTalks West Panels about how workforce shortages are impacting medical device development. The panelists are Nilesh Patel, M.D. Vice President, Medical Affairs, Neuromodulation, Boston Scientific; Farzad Azimpour, M.D. Senior Vice President, Strategic Innovation, Edwards Lifesciences; and Nick West, M.D. Chief Medical Officer, Divisional Vice President, Medical Affairs, Vascular, Abbott. Executive Editor Chris Newmarker deliveres his Newmarker’s Newsmakers – highlighting news from Butterfly Networks, Dentsply Sirona, Stryker, Titan Medical, Johnson & Johnson and Biomed. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to this podcast on all major podcast players.

In this episode, we’ll talk with Keith Grossman, who brought his long, successful track record as a medtech CEO to what he sees as a truly disruptive neurostimulation company. We’ll talk with Grossman about his decision to join medtech even though unlike some of his counterparts he enjoyed organic chemistry (aka, the Medtech career creator) in college. Over his career, Grossman helped create new medical device marks by leading companies such as Thoratec and Conceptus toward sizable acquisitions. At Nevro, Grossman says he’s overseeing the company’s transformation into a pain company, one that’s managed to grab 20% of a competitive market very quickly. Thanks to Pulse Technologies for sponsoring this episode. Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe to this podcast on any major podcast application.

In this episode, Kate Stewart, vice president and general manager of ENT, explains how her first introduction into medical devices came as a patient. Stewart’s Stryker career began in her native Australia but quickly went global. She now leads the ENT business in Minneapolis. Stewart identifies the key leadership quality she’s come to appreciate, pinpoints four critical areas in her specialty, and explains the importance of the Stryker Women’s Network. This episode is sponsored by Boston Micro Fabrication. Thank you for listening to the StrykerTalks Podcast. Subscribe to this podcast on any major podcast application.